MedTrace Logo

Comparative Study 23G Versus 27G Vitrectomy

NCT04216108 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-05-08

No results posted yet for this study

Summary

Investigator-initiated, comparative double-arm, mono-center, prospective, interventional case study to determine whether ultra-small gauge surgery (27G gauge needle) improves postoperative outcome and patient morbidity.

Conditions

  • Vitreoretinal Surgery

Interventions

DEVICE

Vitrectomy (23G gauge needle)

Vitrectomy surgery with 23G gauge needle technique

DEVICE

Vitrectomy (27G gauge needle)

Vitrectomy surgery with 27G gauge needle technique

Sponsors & Collaborators

  • Prof. Dr. Peter Stalmans

    lead OTHER

Principal Investigators

  • Peter Stalmans, MD Phd · UZ Leuven

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2020-03-05
Completion
2020-03-13

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04216108 on ClinicalTrials.gov